Role of LRRK2 in immunity in a nonhuman primate model of SIV
LRRK2 在 SIV 非人灵长类动物模型免疫中的作用
基本信息
- 批准号:10693552
- 负责人:
- 金额:$ 19.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:ANXA5 geneAddressAgonistAttenuatedBacterial InfectionsBasal GangliaBiologicalBiological AssayBiological Response ModifiersBiomedical ResearchBloodBone MarrowBrainCell DeathCellsChronicChronic DiseaseClinicalCorpus striatum structureDNA Sequence AlterationDataDedicationsDevelopment PlansDiseaseDisease modelEncephalitisEnrollmentEnvironmentEnzyme-Linked Immunosorbent AssayEuthanasiaExhibitsFlow CytometryFresh TissueFutureGastrointestinal tract structureGene ExpressionGene ProteinsGenesGoalsGrantGut MucosaHIVHIV InfectionsHIV-1HealthHippocampusHomeostasisHumanImmuneImmune responseImmunityImmunohistochemistryIndividualInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory InfiltrateInterferon Type IIntestinesK-Series Research Career ProgramsKnowledgeLRRK2 geneLeukocytesLife ExpectancyLinkLymphocyteMacacaMacaca mulattaMacrophageMentorsMentorshipMessenger RNAMicrogliaMitochondriaModelingModernizationMonitorMorphologyMucosal ImmunityMusMutateMutationMycobacterium InfectionsNerve DegenerationNeurocognitive DeficitNeurodegenerative DisordersNeurogliaOutcomeParkinson DiseasePathogenesisPathway interactionsPeripheral Blood Mononuclear CellPersonsPhosphorylationPhosphotransferasesPlayPoly I-CPopulationPredispositionPrimatesProductionPropidium DiiodideProteinsRNARecording of previous eventsRegulationReportingResearchResearch PersonnelResourcesRestRiskRoleSIVSeveritiesTestingTherapeuticTherapeutic InterventionTimeTissuesTrainingTuberculosisViralViral Load resultViral PathogenesisVirus DiseasesWestern Blottingantiretroviral therapyantiviral immunitycareercareer developmentchemokinechronic infectioncytokineexperiencefrontal lobeimmune activationimmunoregulationimprovedin vivoinhibitormitochondrial metabolismneuroinflammationneurotoxicnonhuman primateoxidative damagepathogenpathogenic microbepharmacologicresponseseroconversionseropositivetat Protein
项目摘要
Project Summary
While modern therapy has enabled the more than 37 million people living with HIV to experience near normal
life expectancy and transformed it into a manageable chronic disease, neurocognitive impairment remains an
unresolved clinical concern. Increasing evidence indicates that chronic systemic immune activation contributes
to neuroinflammation, and neuroinflammation promotes the severity of neurodegenerative diseases.
Intriguingly, viral-induced neuroinflammation has striking similarities to neurodegenerative disease, and chronic
infection may increase the risk of developing neurodegenerative disease. One factor linked to
neuroinflammation, neurodegeneration, and host immunity against microbial pathogens is the immune kinase
leucine rich repeat kinase 2 (LRRK2). LRRK2 has been implicated in modulating antiviral cytokine activity,
conferring susceptibility to mycobacterial infection, and mutated LRRK2 is the most common monogenetic
cause of the neurodegenerative disorder Parkinson’s disease. The long-term objectives of this proposal are to
extend the observation that LRRK2 modulates antiviral immunity during bacterial infection to determine the
function of LRRK2 in viral pathogenesis and neuroinflammation and assess its therapeutic potential. Using a
macaque SIV infection model for HIV, this proposal seeks to address the fundamental questions of whether
SIV infection promotes LRRK2 expression, and how loss of LRRK2 impacts SIV pathogenesis and the host
immune response. We hypothesize that LRRK2 contributes to HIV pathogenesis through regulation of antiviral
immunity. To test this, we will use a non-human primate (NHP) model to assess the impact of SIV infection on
LRRK2 gene expression and protein levels longitudinally in circulating immune populations and gastrointestinal
tract, and at a single time point in the brain as LRRK2 is dynamically expressed in these tissues. Next, we will
assess the impact of LRRK2 inhibition on host response to SIV using both in vivo and ex vivo approaches. The
data obtained by this project will shed light on the function of LRRK2 in antiviral immune activation and
generate preliminary data for future studies investigating factors contributing to viral-induced
neuroinflammation. The proposed study and Mentored Career Development Plan will be conducted at Tulane
National Primate Center (TNPRC) under the guidance of Drs. Tracy Fisher and Ronald Veazey, experts in viral
induced neuroinflammation and SIV pathogenesis. The TNPRC is a national resource for NHP biomedical
research with a long history of research excellence in viral pathogenesis and therapeutic intervention. The
TNPRC has a strong commitment to training and mentorship demonstrated by extensive financial, effort-
based, and programmatic support to cultivate a rich and diverse training environment for early-stage
investigators. The mentored support and dedicated time provided by the K01 will further Dr. Vail’s career goals
of becoming an independent investigator and NHP researcher studying host pathogen interactions.
项目摘要
虽然现代疗法使3700多万艾滋病毒感染者的经历接近正常,
预期寿命并将其转化为可管理的慢性疾病,神经认知障碍仍然是一个
未解决的临床问题。越来越多的证据表明,慢性全身免疫激活有助于
神经炎症,神经炎症促进神经退行性疾病的严重性。
有趣的是,病毒引起的神经炎症与神经退行性疾病有着惊人的相似之处,
感染可能会增加患神经退行性疾病的风险。一个因素与
神经炎症、神经变性和宿主对微生物病原体的免疫是免疫激酶
富含亮氨酸重复序列激酶2(LRRK 2)。LRRK 2与调节抗病毒细胞因子活性有关,
赋予对分枝杆菌感染的易感性,而突变的LRRK 2是最常见的单基因
帕金森氏症的病因。这项建议的长期目标是
扩展LRRK 2在细菌感染期间调节抗病毒免疫的观察,以确定
LRRK 2在病毒发病机制和神经炎症中的功能,并评估其治疗潜力。使用
猕猴SIV感染HIV的模型,该提案旨在解决以下基本问题:
SIV感染促进LRRK 2表达,以及LRRK 2的缺失如何影响SIV发病机制和宿主
免疫反应我们假设LRRK 2通过调节抗病毒蛋白的表达而参与HIV的发病机制。
免疫力为了验证这一点,我们将使用非人灵长类动物(NHP)模型来评估SIV感染对
循环免疫群体和胃肠道中LRRK 2基因表达和蛋白水平的纵向变化
道,并在单一时间点在大脑中,因为LRRK 2在这些组织中动态表达。接下来我们就
使用体内和离体方法评估LRRK 2抑制对宿主对SIV应答的影响。的
该项目获得的数据将阐明LRRK 2在抗病毒免疫激活中的功能,
为未来的研究提供初步数据,调查导致病毒诱导的
神经炎症拟议的研究和辅导职业发展计划将在杜兰大学进行
国家灵长类动物中心(TNPRC)在病毒专家特雷西·费舍尔(Tracy Fisher)和罗纳德·维齐(Ronald Veazey)博士的指导下
引起的神经炎症和SIV发病机制。TNPRC是NHP生物医学的国家资源
在病毒发病机制和治疗干预方面具有悠久的研究历史。的
TNPRC对培训和指导的坚定承诺体现在广泛的财务,努力-
基础和方案支持,为早期阶段培养丰富多样的培训环境
investigators. K 01提供的指导支持和专门的时间将进一步推动Vail博士的职业目标
成为一名独立的研究者和NHP研究人员,研究宿主病原体的相互作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Krystal Vail其他文献
Krystal Vail的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 19.37万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 19.37万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 19.37万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 19.37万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 19.37万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 19.37万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 19.37万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 19.37万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 19.37万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 19.37万 - 项目类别:
Research Grant